The latest SV company and portfolio news.

6 July 2023
DDF: Unleashing innovation, a new era for dementia
26 June 2023
SV Health Investors Completes Partnership with Packaging Compliance Labs
20 June 2023
SV Health Investors Acquires Robling MedicalRead More
14 June 2023
EyeBio Announces First Patients Dosed in Phase 1b/2 Trial of Restoret™ in Neovascular Age Related Macular Degeneration and Diabetic Macular Edema
31 May 2023
Violet Therapeutics raises $10.6 million in seed funding led by the Dementia Discovery Fund (through DDF-2) and co-led by UTEC (University of Tokyo Edge Capital Partners) and Mass General Brigham Ventures (MGBV)
24 January 2023
Britain is losing its chance to become a life sciences superpowerRead More
16 January 2023
British Patient Capital and Mubadala Invest in SV Biotech Crossover Opportunities Fund
13 December 2022
In its largest single-asset purchase ever, Takeda snaps up TYK2 drug [from SV portfolio company, Nimbus] for $4B upfrontRead More
9 August 2022
On heels of Parkinson’s readout, Cerevance enters Alzheimer’s discovery deal with MerckRead More
31 March 2022
Kate Bingham interviewed by Beth Rigby, Sky News, on the lessons learnt from the UK Vaccine Taskforce
20 March 2022
Fast-track dementia to curb it like CovidRead More
5 December 2021
Kate Bingham FT op-ed: Covid has given UK biotech a lesson — and a legacyRead More
21 October 2021
Xilio Therapeutics Announces Pricing of Initial Public Offering
12 June 2021
Kate Bingham is recognised in this year's Queen’s Birthday Honours List
13 May 2021
Kate Bingham ranks 18th in Fortune's 'World’s 50 Greatest Leaders'Read More
30 April 2021
Houman Ashrafian participated in the Female Founders panel ‘Building a diverse leadership team and board’
22 March 2021
Evidation Raises $153M to Scale Virtual Health Capabilities of Achievement™ Platform
18 March 2021
Wellspring Capital Management Recapitalizes HealthPRO Heritage
17 March 2021
Amathus Therapeutics signs strategic collaboration with Merck to Develop Treatments for Neurodegenerative Diseases
8 February 2021
The Annual Healthcare Growth Update
8 February 2021
Nordic acquires Bails & Associates
3 February 2021
Health Payment Systems, Inc. Welcomes SV Health Investors as New Lead Investor
2 February 2021
AeroCare Announces Completion of Acquisition by AdaptHealth
19 January 2021
Hillrom Announces Planned Acquisition Of Bardy Diagnostics, Inc.
12 January 2021
Boehringer Ingelheim and Enara Bio Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies
11 January 2021
A United Front to Improve Health Outcomes in Northeast Kansas: Healthify's Latest Partnership
6 January 2021
Ribometrix Announces Collaboration with Genentech to Discover and Develop RNA-Targeted Small Molecule Therapeutics
4 January 2021
CareSource and Healthify to Address Social Determinants of Health The two organizations will create a statewide accountable social service network.
15 December 2020
SV Health Investors Promotes Greg Madden to Managing Partner
3 December 2020
Merck KGaA and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
1 December 2020
AdaptHealth Corp. Announces Acquisition of National HME Provider AeroCare Holdings Inc. and Updates Financial Guidance For 2021
23 November 2020
Catamaran Bio Launches with $42 Million Financing to Develop Off-the-Shelf CAR-NK Cell Therapies to Treat Solid Tumors
16 November 2020
Centauri Health Solutions Adds Referral Management and Analytics Capabilities with Acquisition of Ivy Ventures, LLC
14 October 2020
Healthify Partners with Altruista Health to Help Payors Address SDoH

Investing in Women Code Logo

We invest in talented innovators. We strongly adhere to the view that diversity, including under-represented groups, strongly adds to success. If you are an entrepreneur seeking investment and a partner who can help you to build your business, we would love to hear from you. Please get in contact with our team.